Ornek, NurgulOrnek, Kemal2020-06-252020-06-252018closedAccess1746-98991746-9902https://doi.org/10.1080/17469899.2018.1503533https://hdl.handle.net/20.500.12587/7468Introduction: Selective laser trabeculoplasty (SLT) is used successfully for management of early to advanced glaucoma and ocular hypertension (OHT). Primary open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXFG), pigmentary glaucoma, normal-tension glaucoma, primary angle-closure glaucoma, steroid-induced glaucoma, silicone oil-induced glaucoma, and high intraocular pressure after canaloplasty and trabeculectomy are the main indications. Areas covered: A review of the literature was performed to highlight recent advances in terms of suggested mechanisms, indications, efficacy, prognostic factors, surgical technique, postoperative care, complications, repeatability, cost-effectiveness, and quality of life (QoL) implications of SLT in glaucoma patients. Expert commentary: SLT is a safe, cost-effective, and repeatable procedure. It increases QoL, but it has not received wide application it deserves in glaucoma management. SLT may be a first-line treatment option in mild-to-moderate glaucoma. It may also be an adjuvant treatment in OHT and in all subtypes of glaucoma. SLT use may gain popularity in all types of OAGs, closed-angle glaucomas and OHT in the future.eninfo:eu-repo/semantics/closedAccessSelective laser trabeculoplastyglaucomaocular hypertensionintraocular pressuretreatmentReview Article13419120410.1080/17469899.2018.15035332-s2.0-85052279963Q3WOS:000455511500002N/A